AI survey fraud detection in healthcare market research

AI, fraud and the future of healthcare market research

See how AI-driven survey fraud is affecting healthcare market research and how smarter survey design, verification and monitoring can protect data quality.

AI-generated responses and automated participation are creating new challenges for data quality in healthcare market research. As fraud becomes more sophisticated, organizations need practical ways to detect, prevent and mitigate AI-driven interference while protecting the participant experience.

This blog explores AI’s continued impact on market research – used correctly, AI along with human expertise and input, can help reduce fraudulent inauthentic survey responses.

Fraud is rapidly evolving

Fraud has moved far beyond rushed surveys or poor-quality answers. Researchers are now facing AI-generated responses, synthetic participants, duplicate identities and organized fraud networks designed to bypass traditional quality controls.

Recent research suggests that 30–40% of survey data may now contain quality concerns, compared with around 10–15% a few years ago. What was once viewed as isolated respondent fraud is becoming a broader challenge, with technology enabling fraudulent activity at greater speed and scale.

The challenge is no longer just spotting bots

AI has created a detection paradox… the challenge is no longer simply identifying bots but identifying humans using AI.

Large language models can generate thoughtful, varied and contextually relevant responses, follow survey logic and adapt their language. This makes automated participation increasingly difficult to distinguish from genuine human input. At the same time, stronger verification can create friction for genuine participants. If research becomes too complicated or intrusive, healthcare professionals and patients may disengage. The answer is balance – robust safeguards that protect data integrity without compromising the participant experience.

Prevention starts before fieldwork

Fraud prevention cannot begin once data has been collected. By then, poor-quality responses may already have influenced research outcomes.

Fraud can enter at every stage, from fake identities and gameable screening criteria to duplicate participation and AI-generated responses. The strongest defense starts with better research design, smarter recruitment and stronger verification.

This includes harder-to-manipulate screeners, quality-focused recruitment sources, dynamic questioning and a combination of qualitative and quantitative approaches. Survey design itself has become an important tool for protecting data quality because prevention is more effective than cleaning compromised data afterwards.

AI is fighting AI, but technology alone is not enough

Technology has an important role to play in detecting fraudulent behaviour, but no single tool can identify every type of threat. Effective fraud detection relies on multiple layers of quality control working together throughout the research process. Behavioral monitoring, linguistic analysis, device fingerprinting, biometric verification and real-time quality checks are all helping researchers identify suspicious activity.

Behavioral monitoring can identify unusual typing speeds, mouse movements and interaction patterns that indicate automated participation. Linguistic analysis helps to detect overly formulaic or AI-generated open-ended responses, while device fingerprinting cross-checks IP addresses, browsers, devices and timing to identify duplicate respondents, proxy servers and organized bot activity. Hidden quality measures, such as honeypot questions and visual reasoning tasks, provide further opportunities to distinguish genuine human participants from automated systems.

Data quality requires continuous monitoring

Protecting research integrity does not end once fieldwork begins. Continuous quality control throughout the life cycle of a study is equally important.

From soft launch through to final delivery, ongoing monitoring helps to identify unusual response patterns, attempted survey infiltration and emerging quality concerns before they become embedded within the dataset. Where suspicious activity is identified, the value lies not only in removing poor-quality responses but also in feeding those learnings back into recruitment strategies, platform technology and quality assurance processes.

As fraud continues to evolve, quality control must evolve with it. Continuous monitoring and continuous improvement ensure detection methods remain effective against new techniques rather than simply responding to yesterday’s threats.

Synthetic data has a role, but not everywhere

The question is not whether synthetic data is good or bad, but whether it is appropriate. It can support early-stage concept exploration, trend identification and lower-risk research. But for healthcare decisions such as pricing, product launches, brand positioning and patient journey research, human-verified responses remain critical. The higher the stakes, the greater the need for confidence that data reflects genuine human experiences.

Protecting trust in healthcare research

As AI evolves, organizations need to embrace innovation while strengthening the foundations of trust. Data quality is no longer simply a compliance issue; it is fundamental to generating research that healthcare organizations can act upon with confidence.

The future of quality healthcare market research will require intelligent tools, robust research design, rigorous verification and human expertise working together. That’s why Konovo provides protection throughout the research life cycle, safeguarding respondent quality and reliable, high-quality data from start to finish.

Get in touch to explore how AI and smarter survey design can help protect data quality and support better decision-making based on data you can trust.

This blog summarizes some of the key themes explored by Jessica Santos, Chief Compliance & Privacy Officer at Konovo and Mo Rice, Senior Vice President, Business Development at Konovo, in their ‘Rage Against the (Fraud) Machine’ presentation at the EPHMRA Annual Conference 2026.

You may also be interested in:

Healthcare professionals supporting a patient throughout their care journey

Patients are urging pharma to look beyond the physician

Find out how non-physician healthcare professionals influence patients and why pharma needs a broader view of the patient journey and care team....
Keep Reading
People First

People First, AI Second: Rethinking Healthcare Panel Engagement Today 

With nearly every platform claiming to be AI-powered, the real question isn't can we use AI in healthcare research — it's how. The panel's verdict: speed and automation are welcome,...
Keep Reading
Medical Science Liaison

MSLs Matter More Than You Think — If They Get It Right 

Medical Science Liaisons have more influence over oncology treatment decisions than most people assume. But that influence is fragile — and highly conditional. A new Konovo survey of 100 US...
Keep Reading